PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $13.5 million in its first quarter.
The Pleasanton, California-based company said it had a loss of 10 cents per share.
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The life science technology company posted revenue of $150.8 million in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $145.6 million.
10x Genomics expects full-year revenue in the range of $600 million to $625 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
